Efficacy of Ceftazidime-Avibactam in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection After Kidney Transplantation

PURPOSE: The clinical efficacy of ceftazidime-avibactam (CAZ-AVI) in treating carbapenem-resistant Klebsiella pneumoniae (CRKP)-infected recipients after kidney transplantation (KT) has not been well evaluated. We aimed to assess its efficacy in a single-center cohort of KT recipients infected with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fei, Zhong, Jinbiao, Ding, Handong, Liao, Guiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664339/
https://www.ncbi.nlm.nih.gov/pubmed/34908850
http://dx.doi.org/10.2147/IDR.S343505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664339/
https://www.ncbi.nlm.nih.gov/pubmed/34908850
http://dx.doi.org/10.2147/IDR.S343505

Ejemplares similares